CBDY on OTC
Target Group Inc.
American medicinal chemicals and botanical products company. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with HEALTHY EXTRACTS INC., PANACEA LIFE SCIENCES HOLDINGS, INC. or Functional Brands Inc., or pick any stock.
- TickerCBDY on OTC1
- IndustryMedicinal Chemicals & Botanical Products1
- HeadquartersDE1
- Incorporated inDE2
- Business address20 Hempstead Drive, Hamilton, L8W 2E72
- Filer categoryNon-accelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
Target Group Inc. (“Target Group” or the “Company”) was incorporated in the State of Delaware on July 2, 2013, under its original name of River Run Acquisition Corporation. Effective May 13, 2014, the Company changed its name to Chess Supersite Corporation. On July 3, 2018, the Company filed an amendment in its Certificate of Incorporation to change its name to Target Group Inc.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue47¢$1.8M
- Other costs53¢$2.1M
Out of $3.9M in revenue.4 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| REVENUE | $3.9M | $6.6M |
| COST OF GOOD SOLD | -$1.8M | -$2.9M |
| Gross profit | $2.1M | $3.7M |
| Advisory and consultancy fee | $171.2K | $256.2K |
| Management services fee | $405.3K | $477.0K |
| Legal and professional fees | $202.0K | $218.8K |
| Depreciation expense | $898.4K | $916.2K |
| Operating lease expense | $193.9K | $217.4K |
| Office and general | $418.6K | $515.6K |
| Travel expenses | $7.3K | |
| Total operating expenses | $2.3M | $2.6M |
| Change in fair value of derivative and warrant liability | $140 | -$374 |
| Gain on settlement | -$36.5K | |
| Interest and bank charges | $1.0M | $1.2M |
| Exchange loss (income) | $98.6K | -$172.6K |
| Interest income | -$34.1K | -$30.8K |
| Recovery of sales tax recoverable | -$653 | -$6.1K |
| Debt issuance cost | $29.7K | $49.0K |
| Total other expense | $1.1M | $956.2K |
| Net (loss) income before income taxes | -$1.4M | $160.5K |
| Income taxes | $0 | $0 |
| Net (loss) income | -$1.4M | $160.5K |
| Foreign currency translation adjustment | -$195.6K | $304.6K |
| Comprehensive (loss) income | -$1.6M | $465.1K |
| loss per share - basic (in dollars per share) | -$0.00 | $0.00 |
| loss per share - diluted (in dollars per share) | -$0.00 | $0.00 |
| Weighted average shares - basic (in shares) | 617.0M shares | 617.0M shares |
| Weighted average shares - diluted (in shares) | 617.0M shares | 727.2M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $100.4K | $1.9M | |
| Restricted cash | $8.4K | $8.0K | |
| Accounts receivable, net of allowance | $446.3K | $77.1K | |
| Inventory | $1.7M | $882.3K | |
| Prepaid asset | $41.2K | $39.3K | |
| Convertible note receivable | $139.0K | ||
| Interest receivable | $29.3K | ||
| Sales tax recoverable, net of allowance | $60.5K | $53.7K | |
| Other receivable | $3.6K | $3.5K | |
| Total current assets | $2.3M | $3.1M | |
| Fixed assets | $3.6M | $4.2M | |
| Goodwill | $260.0K | $247.7K | |
| Operating lease right-of-use assets | $32.8K | $38.4K | |
| Total long term assets | $3.8M | $4.5M | |
| Total assets | $6.2M | $7.6M | |
| Bank overdraft | $506 | $506 | |
| Accounts payable and accrued liabilities | $2.6M | $3.1M | |
| Deferred revenue | $197.6K | ||
| Payable to related parties, net | $10.4M | $9.9M | |
| Operating lease liability - Current portion | $175.5K | $140.2K | |
| Convertible promissory notes, net | $480 | $480 | |
| Derivative liability | $8.1K | $8.0K | |
| Total current liabilities | $13.4M | $13.1M | |
| Operating lease liability - Non-current portion | $858.1K | $984.7K | |
| Warrant liability | $42 | ||
| Total long term liabilities | $858.1K | $984.7K | |
| Total liabilities | $14.2M | $14.1M | |
| Preferred stock | $100 | $100 | |
| Common stock | $61.7K | $61.7K | |
| Shares to be issued | $175.4K | $175.4K | |
| Additional paid-in capital | $25.0M | $25.0M | |
| Accumulated deficit | -$32.3M | -$30.9M | |
| Accumulated comprehensive loss | -$979.4K | -$783.7K | |
| Total stockholders' deficiency | -$8.1M | -$6.5M | -$7.0M |
| Total liabilities and stockholders' deficiency | $6.2M | $7.6M |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash | $100.4K | $1.9M | |
| Restricted cash | $8.4K | $8.0K | |
| Accounts receivable, net of allowance | $446.3K | $77.1K | |
| Inventory | $1.7M | $882.3K | |
| Prepaid asset | $41.2K | $39.3K | |
| Convertible note receivable | $139.0K | ||
| Interest receivable | $29.3K | ||
| Sales tax recoverable, net of allowance | $60.5K | $53.7K | |
| Other receivable | $3.6K | $3.5K | |
| Total current assets | $2.3M | $3.1M | |
| Fixed assets | $3.6M | $4.2M | |
| Goodwill | $260.0K | $247.7K | |
| Operating lease right-of-use assets | $32.8K | $38.4K | |
| Total long term assets | $3.8M | $4.5M | |
| Total assets | $6.2M | $7.6M | |
| Bank overdraft | $506 | $506 | |
| Accounts payable and accrued liabilities | $2.6M | $3.1M | |
| Deferred revenue | $197.6K | ||
| Payable to related parties, net | $10.4M | $9.9M | |
| Operating lease liability - Current portion | $175.5K | $140.2K | |
| Convertible promissory notes, net | $480 | $480 | |
| Derivative liability | $8.1K | $8.0K | |
| Total current liabilities | $13.4M | $13.1M | |
| Operating lease liability - Non-current portion | $858.1K | $984.7K | |
| Warrant liability | $42 | ||
| Total long term liabilities | $858.1K | $984.7K | |
| Total liabilities | $14.2M | $14.1M | |
| Preferred stock | $100 | $100 | |
| Common stock | $61.7K | $61.7K | |
| Shares to be issued | $175.4K | $175.4K | |
| Additional paid-in capital | $25.0M | $25.0M | |
| Accumulated deficit | -$32.3M | -$30.9M | |
| Accumulated comprehensive loss | -$979.4K | -$783.7K | |
| Total stockholders' deficiency | -$8.1M | -$6.5M | -$7.0M |
| Total liabilities and stockholders' deficiency | $6.2M | $7.6M |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net (loss) income for the year | -$1.4M | $160.5K |
| Change in fair value of derivative and warrant liability | $140 | -$374 |
| Gain on settlement | -$36.5K | |
| Recovery of sales tax recoverable | -$653 | -$6.1K |
| Depreciation expense | $898.4K | $916.2K |
| Operating lease expense | $178.8K | $200.8K |
| Debt issuance cost | $29.7K | $49.0K |
| Change in accounts receivable - net of allowance | -$358.5K | $915.4K |
| Change in other assets | $53.4K | |
| Change in inventory | -$728.6K | $247.3K |
| Change in sales tax recoverable | -$3.4K | -$97.2K |
| Change in accounts payable and accrued liabilities | $606.1K | $151.8K |
| Change in operating lease liability, net | -$315.9K | -$319.1K |
| Changes in interest receivable | $17.3K | -$30.8K |
| Change in deferred revenue | $193.8K | -$41.6K |
| Net cash (used) provided from operating activities | -$842.4K | $2.2M |
| Amounts invested on fixed assets | -$74.6K | -$69.4K |
| Advancement on convertible note | $156.0K | -$146.0K |
| Recoverable expense | $36.5K | |
| Net cash provided (used) by investing activities | $81.4K | -$179.0K |
| Settlement of related party loan | -$1.1M | -$730.2K |
| Net cash (used) by financing activities | -$1.1M | -$730.2K |
| Net change in cash and restricted cash during the year | -$1.8M | $1.3M |
| Effect of foreign currency translation | $56.9K | -$120.7K |
| Cash paid for interest | $1.6M | $933.5K |
No quarter-by-quarter statement was filed.
Leadership
Who has led Target Group Inc., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
- Chief executive officerAnthony Carlo Zarcone Mar 31, 2020 to Mar 31, 202013
- Chief executive officerAlexander Starr Feb 11, 2016 to Mar 23, 201714
- Chief executive officerRubin Schindermann Mar 9, 2015 to Sep 27, 201915
- PresidentAlexander Starr Mar 9, 2015 to Apr 9, 201916
- PresidentJames M. Cassidy Feb 19, 2014 to Feb 19, 201417
- Chief financial officerAzmatali Mehrali Jun 19, 2019 to Jun 19, 201918
Board members and other officers (9)
- vice presidentJames K. McKillop Feb 19, 2014 to Feb 19, 201419
- Board memberBarry Alan Katzman Nov 5, 2020 to Nov 5, 202020
- Board memberAnthony Carlo Zarcone Oct 25, 2019 to Mar 31, 202021
- Board memberFrank Michael Monte Oct 25, 2019 to Oct 25, 201922
- Board memberSaul Niddam Oct 25, 2019 to Oct 25, 201923
- Board memberAlexander Starr Mar 9, 2015 to Apr 9, 201916
- Board memberRubin Schindermann Mar 9, 2015 to Aug 21, 202015
- Board memberJames K. McKillop Feb 19, 2014 to Feb 19, 201419
- Board memberJames M. Cassidy Feb 19, 2014 to Feb 19, 201417
Former names
Timeline
Filings
32 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 11 major events. The latest 20:
- Aug 13, 202610-Q EDGAR
- May 15, 202610-Q EDGAR
- Mar 31, 202610-K EDGAR
- Nov 7, 202510-Q EDGAR
- Aug 18, 20258-K EDGAR
- Aug 12, 202510-Q EDGAR
- May 9, 202510-Q EDGAR
- Mar 27, 202510-K EDGAR
- Nov 7, 202410-Q EDGAR
- Aug 26, 20248-K EDGAR
- Aug 8, 202410-Q EDGAR
- May 8, 202410-Q EDGAR
- Mar 20, 202410-K EDGAR
- Nov 13, 20238-K EDGAR
- Nov 8, 202310-Q EDGAR
- Aug 9, 202310-Q EDGAR
- Aug 4, 20238-K/A EDGAR
- May 8, 202310-Q EDGAR
- Mar 31, 20238-K/A EDGAR
- Mar 27, 20238-K EDGAR
The 32 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARAlexander Starr, President
- 17SEC EDGARJames M. Cassidy, President
- 18
- 19SEC EDGARJames K. McKillop, vice president
- 20SEC EDGARBarry Alan Katzman, Board member
- 21SEC EDGARAnthony Carlo Zarcone, Board member
- 22SEC EDGARFrank Michael Monte, Board member
- 23SEC EDGARSaul Niddam, Board member